Pharmocann to develop drugs based on magic mushrooms
Psilocybe semilanceata, magic mushrooms Pharmocann, an Israeli firm that specializes in medical cannabis products, has established a joint venture with the Shamir Research Institute to conduct research and development on psychedelic medications derived from psilocybin semilanceata mushrooms (magic mushrooms). Psilocybin, or liberty cap is a fungus that produces psychoactive compounds. Whether fresh or dried it is […]
Continue Reading